Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
160,395,186
-
Share change
-
-9,117,621
-
Total reported value
-
$37,502,672,698
-
Put/Call ratio
-
132%
-
Price per share
-
$233.87
-
Number of holders
-
1,002
-
Value change
-
-$2,138,732,747
-
Number of buys
-
380
-
Number of sells
-
591
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q2 2019
As of 30 Jun 2019,
BIOGEN INC. - COM (BIIB) was held by
1,002 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
160,395,186 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, STATE STREET CORP, Clearbridge Investments, LLC, Capital World Investors, WELLINGTON MANAGEMENT GROUP LLP, AQR CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and Invesco Ltd..
This page lists
1,003
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.